Driving reinvestment in R&D for antibiotics and advocating their responsible use

News

The Lancet Series launched to celebrate Global Antibiotic Awareness Day

In celebration of Global Antibiotic Awareness Day, 18 November 2015, The Lancet, in collaboration with Imperial College London and the Norwegian Institute of Public Health, is publishing a new series titled: “Antimicrobials: sustainable access and effectiveness”. The five papers in the series cover access to effective antimicrobials as a global challenge, understanding the mechanisms and the drivers of antimicrobial resistance, maximising access to achieve appropriate human antimicrobial use in low- and middle-income countries,  exploring the evidence base for national and regional policy interventions to combat resistance, and international cooperation to improve access to and sustain effectiveness of antimicrobials. The launch of the series will...
Read more

UK & China to establish Global Antimicrobial Resistance Research Innovation Fund

During Chinese President Xi Jinping's State Visit to the UK, UK Prime Minister announced a new fund to drive a global response to antimicrobial resistance. The UK and China will establish the Global Antimicrobial resistance Research Innovation Fund and encourage further investment from other governments and the private sector, helping to address one of the greatest problems facing the world of medicine today.   To read more on this story, click here....
Read more

DRIVE-AB participants to present at meeting of the Transatlantic Taskforce on Antimicrobial Resistance

The Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) will meet in Luxembourg City, Luxembourg, on 22-23 October 2015 to discuss synergies between Europe and North America in antimicrobial resistance strategies. Major topics will include, among others,  - Action on antimicrobial resistance on both sides of the Atlantic - How do we keep new antibiotics effective? Balancing access and conservation - TATFAR in context: International initiatives on antimicrobial resistance DRIVE-AB participants John-Arne Røttingen (work package 2 co-lead), Ursula Theuretzbacher (work package 3B co-lead), and Otto Cars will be presenting at the meeting. Click here to view...
Read more

DRIVE-AB holds second annual General Assembly

A DRIVE-AB General Assembly was held at Uppsala University in Uppsala, Sweden on 15-16 October 2015. The two-day meeting brought together DRIVE-AB participants from all over the world to discuss DRIVE-AB progress, challenges, and next steps. Each work package presented its progress to date, and opportunities for further collaboration between work packages was explored. In-depth discussions were also held about DRIVE-AB in the context of other global AMR initiatives, stakeholder engagement, how to implement eventual outputs, and the logistics of successfully running a global project. Please click here to view the Agenda: DRIVE-AB General Assembly 2015.     IMG_1582 Read more

DRIVE-AB funded article on the burden of antibiotic resistance on surgery and cancer chemotherapy published in the Lancet Infectious Diseases

DRIVE-AB partner Ramanan Laxminarayan has co-authored an article published in Lancet Infectious Diseases on October 16, 2015. The article, "Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study". The article has received significant media attention with mentions by the BBC, among others....
Read more